CO-CHAIRMAN of $HLI Sells 40,000 Shares in Insider Sale

Paul Eric Siegert, the co-chairman of the company with the ticker symbol $HLI, recently made headlines by selling a substantial amount of company shares. Siegert sold a total of 40,000 shares on August 27, 2025, which amounted to an impressive $7,998,000. This transaction, documented in a recent SEC filing, involved the sale of all of Siegert’s shares in this particular class of stock, leaving him with a holding of zero shares in $HLI.

This was not an isolated incident of insider trading within the company. A closer look at $HLI’s recent trading history reveals that insiders have engaged in a total of 9 transactions on the open market over the past 6 months, with all 9 transactions being sales rather than purchases. In addition to Siegert, other key figures within the company such as co-chairman Scott L Beiser and Irwin Gold have also offloaded significant amounts of shares. Notably, Gillian Beth Zucker has been involved in 5 sales transactions, while Christopher M Crain, the general counsel of $HLI, has made a smaller sale of 500 shares.

Shifting the focus to institutional investors, the data shows that 261 institutions have added $HLI shares to their holdings, while 300 others have decreased their positions in the most recent quarter. Notable movements include Gamma Investing LLC’s substantial removal of over 99% of their $HLI shares, corresponding to a staggering $122,664,177. On the other hand, Champlain Investment Partners, LLC saw a significant increase of almost 195% in their $HLI stake.

Congressional involvement in $HLI stock trading has also been documented, with two recorded transactions in the past 6 months. Representative Kelly Morrison and Representative Josh Gottheimer were involved in sales transactions, each selling up to $15,000 worth of $HLI stock on different dates.

Moreover, Wall Street analysts have been closely monitoring $HLI, with 3 firms issuing buy ratings for the stock in recent months. Notably, Keefe, Bruyette & Woods, Wells Fargo, and Morgan Stanley have all issued favorable ratings, indicating confidence in $HLI’s performance.

Lastly, analysts have set a median target price of $200.5 for $HLI, with individual targets ranging from $192.0 to $232.0. In summary, despite Siegert’s significant sale of shares, $HLI continues to attract attention from investors and analysts alike.